Diede Van den Ouden

Track

Insider profile

Performance

Overall performance
2.3
Performance over holding periods
4.2
30 days 90 days 120 days
Average return 29% 8.2% 15.1%
Success rate 86% 68% 82%
Transactions
6 83% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return 79%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance
Diede Van den Ouden's trades of TME Pharma NV's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
NL TME Pharma NV (ALTME)
Transaction date
Sale
Price
118.43
Quantity 8,951
Value €4,943,512
NL TME Pharma NV (ALTME)
Transaction date
Purchase
Price
320.98
Quantity 48,481
Value €2,157,941
NL TME Pharma NV (ALTME)
Transaction date
Purchase
Price
45.54
Quantity 33,592
Value €3,076,168
NL TME Pharma NV (ALTME)
Transaction date
Purchase
Price
0.10
Quantity 30,000
Value €3,000
NL TME Pharma NV (ALTME)
Transaction date
Purchase
Price
0.10
Quantity 95,000
Value €9,500
NL TME Pharma NV (ALTME)
Transaction date
Purchase
Price
0.09
Quantity 300,000
Value €27,000
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-28 2026-08-26
NL TME Pharma NV (ALTME)
S Sale
8,951
118.43
€4,943,512 		8,951 118.43 €4,943,512
2025-10-02 2025-09-25
NL TME Pharma NV (ALTME)
B Purchase
48,481
320.98
€2,157,941 		48,481 320.98 €2,157,941
2025-10-02 2025-09-24
NL TME Pharma NV (ALTME)
B Purchase
33,592
45.54
€3,076,168 		33,592 45.54 €3,076,168
2025-10-02 2025-09-23
NL TME Pharma NV (ALTME)
B Purchase
30,000
0.10
€3,000 		30,000 0.10 €3,000
2025-10-02 2025-09-22
NL TME Pharma NV (ALTME)
B Purchase
95,000
0.10
€9,500 		95,000 0.10 €9,500
2025-09-25 2025-09-19
NL TME Pharma NV (ALTME)
B Purchase
300,000
0.09
€27,000 		300,000 0.09 €27,000